Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
EBioMedicine ; 88: 104435, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36628844

ABSTRACT

BACKGROUND: To date, only a few studies reported data regarding the development of mucosal immune response after the BNT162b2-booster vaccination. METHODS: Samples of both serum and saliva of 50 healthcare workers were collected at the day of the booster dose (T3) and after two weeks (T4). Anti-S1-protein IgG and IgA antibody titres and the neutralizing antibodies against the Wuhan wild-type Receptor-Binding Domain in both serum and saliva were measured by quantitative and competitive ELISA, respectively. Data were compared with those recorded after the primary vaccination cycle (T2). Neutralizing antibodies against the variants of concern were measured in those individuals with anti-Wuhan neutralizing antibodies in their saliva. FINDINGS: After eight months from the second dose, IgG decreased in both serum (T2GMC: 23,838.5 ng/ml; T3GMC: 1473.8 ng/ml) and saliva (T2GMC: 12.9 ng/ml; T3GMC: 0.3 ng/ml). Consistently, serum IgA decreased (T2GMC: 48.6 ng/ml; T3GMC: 6.4 ng/ml); however, salivary IgA showed a different behaviour and increased (T2GMC: 0.06 ng/ml; T3GMC: 0.41 ng/ml), indicating a delayed activation of mucosal immunity. The booster elicited higher titres of both IgG and IgA when compared with the primary cycle, in both serum (IgG T4GMC: 98,493.9 ng/ml; IgA T4GMC: 187.5 ng/ml) and saliva (IgG T4GMC: 21.9 ng/ml; IgA T4GMC: 0.65 ng/ml). Moreover, the booster re-established the neutralizing activity in the serum of all individuals, not only against the Wuhan wild-type antigen (N = 50; INH: 91.6%) but also against the variants (Delta INH: 91.3%; Delta Plus INH: 89.8%; Omicron BA.1 INH: 85.1%). By contrast, the salivary neutralizing activity was high against the Wuhan antigen in 72% of individuals (N = 36, INH: 62.2%), but decreased against the variants, especially against the Omicron BA.1 variant (Delta N = 27, INH: 43.1%; Delta Plus N = 24, INH: 35.2%; Omicron BA.1 N = 4; INH: 4.7%). This was suggestive for a different behaviour of systemic immunity observed in serum with respect to mucosal immunity described in saliva (Wald chi-square test, 3 df of interaction between variants and sample type = 308.2, p < 0.0001). INTERPRETATION: The BNT162b2-booster vaccination elicits a strong systemic immune response but fails in activating an effective mucosal immunity against the Omicron BA.1 variant. FUNDING: This work was funded by the Department of Medicine and Surgery, University of Insubria, and supported by Fondazione Umberto Veronesi (COVID-19 Insieme per la ricerca di tutti, 2020), Italy.


Subject(s)
COVID-19 , Immunity, Mucosal , Humans , BNT162 Vaccine , COVID-19/prevention & control , COVID-19 Vaccines , Antibodies, Neutralizing , Immunoglobulin A , Immunoglobulin G , Antibodies, Viral , Vaccination
2.
EBioMedicine ; 75: 103788, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34954658

ABSTRACT

BACKGROUND: Although the BNT162b2 COVID-19 vaccine is known to induce IgG neutralizing antibodies in serum protecting against COVID-19, it has not been studied in detail whether it could generate specific immunity at mucosal sites, which represent the primary route of entry of SARS-CoV-2. METHODS: Samples of serum and saliva of 60 BNT162b2-vaccinated healthcare workers were collected at baseline, two weeks after the first dose and two weeks after the second dose. Anti-S1-protein IgG and IgA total antibodies titres and the presence of neutralizing antibodies against the Receptor Binding Domain in both serum and saliva were measured by quantitative and by competitive ELISA, respectively. FINDINGS: Complete vaccination cycle generates a high serum IgG antibody titre as a single dose in previously infected seropositive individuals. Serum IgA concentration reaches a plateau after a single dose in seropositive individuals and two vaccine doses in seronegative subjects. After the second dose IgA level was higher in seronegative than in seropositive subjects. In saliva, IgG level is almost two orders of magnitude lower than in serum, reaching the highest values after the second dose. IgA concentration remains low and increases significantly only in seropositive individuals after the second dose. Neutralizing antibody titres were much higher in serum than in saliva. INTERPRETATION: The mRNA BNT162b2 vaccination elicits a strong systemic immune response by drastically boosting neutralizing antibodies development in serum, but not in saliva, indicating that at least oral mucosal immunity is poorly activated by this vaccination protocol, thus failing in limiting virus acquisition upon its entry through this route. FUNDING: This work was funded by the Department of Medicine and Surgery, University of Insubria, and partially supported by Fondazione Umberto Veronesi (COVID-19 Insieme per la ricerca di tutti, 2020).


Subject(s)
Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , BNT162 Vaccine/administration & dosage , COVID-19/immunology , Immunity, Mucosal/drug effects , Immunization, Secondary , Adult , BNT162 Vaccine/immunology , COVID-19/prevention & control , Female , Health Personnel , Humans , Immunoglobulin A/immunology , Immunoglobulin G/immunology , Male , Middle Aged , Saliva/immunology
3.
JAMA Ophthalmol ; 139(9): 956-963, 2021 09 01.
Article in English | MEDLINE | ID: mdl-33662099

ABSTRACT

Importance: Since February 2020, coronavirus disease 2019 (COVID-19) has spread rapidly all over the world, with an epidemiological cluster in Lombardy, Italy. The viral communicability may be mediated by various body fluids, but insufficient information is available on the presence of the virus in human tears. Objectives: To investigate the rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tears collected from patients with COVID-19 by means of real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) assay and to assess the association of virus presence with concomitant clinical conditions. Design, Setting, and Participants: Cross-sectional study conducted between April 9 and May 5, 2020. The setting was intensive care units at Azienda Socio-Sanitaria Territoriale (ASST) Sette-Laghi Hospital, University of Insubria, in Varese, Lombardy, Italy. A conjunctival swab was performed in 91 patients hospitalized for COVID-19, which was clinically diagnosed by rRT-PCR assay on nasopharyngeal swabs and by radiological imaging. Conjunctival swabs from 17 additional healthy volunteer participants with no symptoms of COVID-19 were examined to evaluate the availability and applicability of the conjunctival swab test. Exposure: SARS-CoV-2 detection by means of rRT-PCR assay performed on the collected samples obtained by conjunctival swabs. Main Outcomes and Measures: Conjunctival swab and nasopharyngeal swab results are reported, as well as demographic and clinical data. Results: A total of 108 participants (mean [SD] age, 58.7 [14.2] years; 55 female and 53 male) were tested for SARS-CoV-2 using rRT-PCR assay, including 91 patients hospitalized with COVID-19 and 17 were healthy volunteers. SARS-CoV-2 was found on the ocular surface in 52 of 91 patients with COVID-19 (57.1%; 95% CI, 46.3%-67.5%), with a wide variability in the mean viral load from both eyes. Among a subset of 41 patients, concordance of 63.0% (95% CI, 41.0%-81.0%) was found between positive conjunctival and nasopharyngeal swab test results when performed within 2 days of each other. In 17 of these patients, nasopharyngeal swab results were negative for SARS-CoV-2. In 10 of these 17 patients, conjunctival swab results were positive for the virus. Conclusions and Relevance: In this study, SARS-CoV-2 RNA was found on the ocular surface in a large part of this cohort of patients with COVID-19, although the infectivity of this material could not be determined. Because patients may have positive test results with a conjunctival swab and negative results with a nasopharyngeal swab, use of the slightly invasive conjunctival swab may be considered as a supplementary diagnostic test.


Subject(s)
COVID-19/virology , Conjunctiva/virology , RNA, Viral/isolation & purification , SARS-CoV-2/isolation & purification , Tears/virology , Adult , Aged , Aged, 80 and over , COVID-19/diagnosis , COVID-19 Nucleic Acid Testing , Cross-Sectional Studies , Female , Humans , Italy , Male , Middle Aged , Nasopharynx/virology , Predictive Value of Tests , RNA, Viral/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , SARS-CoV-2/genetics , Specimen Handling
5.
J Infect ; 81(1): e45-e50, 2020 07.
Article in English | MEDLINE | ID: mdl-32298676

ABSTRACT

OBJECTIVES: This study analyzed salivary samples of COVID-19 patients and compared the results with their clinical and laboratory data. METHODS: Salivary samples of 25 COVID-19 patients were analyzed by rRT-PCR. The following data were collected: age, sex, comorbidities, drugs. Lactate dehydrogenase (LDH) and ultrasensitive reactive C protein (usRCP) values were registered on the same day when a salivary swab was collected. Prevalence of positivity in saliva and association between clinical data and the cycle threshold as a semiquantitative indicator of viral load were considered. RESULTS: Twenty-five subjects were recruited into this study, 17 males and 8 females. The mean age was 61.5 +/- 11.2 years. Cardiovascular and/or dysmetabolic disorders were observed in 65.22% of cases. All the samples tested positive for the presence of SARS-CoV-2, while there was an inverse association between LDH and Ct values. Two patients showed positive salivary results on the same days when their pharyngeal or respiratory swabs showed conversion. CONCLUSIONS: Saliva is a reliable tool to detect SARS-CoV-2. The role of saliva in COVID-19 diagnosis could not be limited to a qualitative detection of the virus, but it may also provide information about the clinical evolution of the disease.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Saliva/virology , Aged , Aged, 80 and over , Betacoronavirus/genetics , COVID-19 , Coronavirus Infections/virology , Female , Humans , Male , Middle Aged , Pandemics , Pneumonia, Viral/virology , Real-Time Polymerase Chain Reaction , SARS-CoV-2
6.
Oral Dis ; 25(6): 1634-1644, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31066953

ABSTRACT

OBJECTIVE: The purpose of this case-control study was to compare the pharmacological anamnesis collected from a group of 150 burning mouth syndrome (BMS) patients with that of a control group of 150 patients matched for age and sex. MATERIALS AND METHODS: The patients' medical histories were reviewed, and data on drug therapy were collected. Drugs were classified on the basis of pharmacological effects; the classes were antihypertensives (i.e., ACE inhibitors/ARBs, calcium antagonists, diuretics and beta-blockers), antiaggregants, anticoagulants, antidiabetics, vitamin D integrators, bisphosphonates, psychotropics (i.e., anxiolytics and antidepressants), gastroprotectors, statins, thyroid hormone substitutes, corticosteroids and immunosuppressants. RESULTS: The BMS patients and the controls were matched for age (mean age: 69 years) and sex (128 females and 22 males). Antihypertensives, especially ACE inhibitors/ARBs (OR = 0.37, CI: 0.22-0.63, p = 0.0002) and beta-blockers (OR = 0.36, CI: 0.19-0.68 p = 002), revealed an inverse association with the presence of BMS, whereas anxiolytics (OR = 3.78, CI: 2.12-6.75 p < 0.0001), but neither antidepressants nor antipsychotics, were significantly associated with BMS. There were no correlations with other drug classes. CONCLUSION: Our study highlighted that ACE inhibitors, ARBs and beta-blockers were in inverse relation to BMS and found that anxiolytics, but neither antidepressants nor antipsychotics, were linked to the presence of the syndrome.


Subject(s)
Adrenergic beta-Antagonists/adverse effects , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Antidepressive Agents/adverse effects , Antipsychotic Agents/adverse effects , Burning Mouth Syndrome , Adrenergic beta-Antagonists/administration & dosage , Adult , Aged , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Antidepressive Agents/administration & dosage , Antipsychotic Agents/administration & dosage , Case-Control Studies , Female , Humans , Male , Middle Aged
7.
Oral Dis ; 25(6): 1465-1491, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30457193

ABSTRACT

Chronic ulcerative stomatitis (CUS) is an immune-mediated disorder characterized by oral erosions and ulcers usually refractory to conventional treatments. The disease often involves middle-aged and older women with painful lesions sometimes resembling those of erosive oral lichen planus (OLP). The most affected sites are the buccal mucosa, the gingiva and the tongue, but the skin is involved in 22.5% of cases. Histopathologic features in CUS are non-specific and indistinguishable from those of OLP, with the exception of the presence of a mixed infiltrate composed of lymphocytes and plasma cells. Direct immunofluorescence (DIF) analysis reveals the presence of stratified epithelium-specific antinuclear antibodies (SES-ANA) in the lower third of the epithelium. The IgG antibodies detected on DIF are directed against the ∆Np63α isoform of p63 expressed in the nuclei of the epithelial basal cells. A distinguishing feature of CUS is the low response to conventional corticosteroid therapy and the good outcome with hydroxychloroquine at the dosage of 200 mg/day or higher dosages. This paper presents a comprehensive review of CUS and is accompanied by a new case report (the 73rd case) and a proposal for updated diagnostic criteria.


Subject(s)
Antibodies, Antinuclear/immunology , Gingivitis, Necrotizing Ulcerative/immunology , Stomatitis , Aged , Anti-Inflammatory Agents/therapeutic use , Antibodies, Antinuclear/analysis , Female , Gingivitis, Necrotizing Ulcerative/drug therapy , Gingivitis, Necrotizing Ulcerative/pathology , Humans , Hydroxychloroquine/therapeutic use , Immunoglobulin G/analysis , Lichen Planus, Oral/diagnosis , Middle Aged
8.
Case Rep Dent ; 2017: 9604570, 2017.
Article in English | MEDLINE | ID: mdl-28280638

ABSTRACT

A small radiolucent area in the mandible was discovered in a 58-year-old woman with no oral complaints. The patient's history included only hypertension. The lesion was considered as an inflammatory cyst and was enucleated. Three months later, a CT revealed the presence of a cyst-like lesion in the mandible with thin expanded buccal cortical plate, localized erosion, and a polylobate appearance on the lingual aspect of the cortical plate. The histological diagnosis of the lesion was central giant-cell granuloma (CGCG). The lesion was thoroughly enucleated. Nevertheless, another X-ray carried out six months later revealed multiple bilateral osteolytic areas throughout the jaw. In addition, widespread cortical plate erosion was observed, as well as signs of root resorption and periodontal enlargement. There was no sign of neurological involvement, although the nerves appeared to be dislocated. After full blood chemistry analysis and detailed collection of radiographs, the final diagnosis was brown tumors in primary hyperparathyroidism. This case report demonstrates how dental clinicians may be the first-line specialists who identify a complex systemic disease before other clinicians. Finally, it highlights the role of cellular cannibalism in predicting the clinical aggressiveness of brown tumors as well as in other giant-cell lesions.

9.
Minerva Stomatol ; 65(4): 223-30, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27374362

ABSTRACT

BACKGROUND: Scientific studies show a possible influence of intercellular and intracellular proteins (VEGF) on the development of physiological and pathological tissue. VEGF, a key regulator of angiogenesis, it would seem essential to take action during the embryonic development of the dental germ. The purpose of the study is to investigate the importance of the enzymatic activity of VEGF through protein quantification at different stages of tooth germ development. METHODS: The quantification of VEGF protein was performed by 3 different laboratory tests: Western-blot analysis, semi-quantitative reverse transcriptase-polymerase chain reaction analysis (RT-PCR) and finally immunohistochemical analysis. Cell cultures of tooth tissue examined are: endothelial cells, stellate reticulum cells, odontoblasts and ameoblast. RESULTS: The VEGF peptide seems to induce an intense cell proliferation, not concomitant with differentiation towards the endothelial line. The expression of VEGF in the inner enamel epithelium (ameloblasts) would seem to depend on the stage of differentiation, leading us to deduce that VEGF and its respective receptor are expressed in dental germ and that induce alterations not only on the vascularization, but also on the inner epithelium activation and then on dental enamel development, respectively on cap and bell stages of embryogenesis. CONCLUSIONS: In our survey, the positive expression of VEGF in all the samples examined, might suggest a fundamental role of angiogenic gene proteins during all stages of embryonic tooth development. It is also characteristic the behavior of stellate reticulum cells, with a significant reduction in VEGF action between early and late stage, which could suggest a possible role of stellate reticulum cells, which would be able to promote and maintain an adequate energy supply to the tissues during early and late stages of differentiation and proliferation.


Subject(s)
Tooth Germ/metabolism , Vascular Endothelial Growth Factor A/analysis , Adolescent , Ameloblasts/metabolism , Blotting, Western , Child , Endothelial Cells/metabolism , Female , Gene Expression Regulation, Developmental , Humans , Male , Odontoblasts/metabolism , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Tooth Germ/growth & development , Vascular Endothelial Growth Factor A/biosynthesis , Young Adult
10.
J Oral Pathol Med ; 44(3): 229-33, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25155153

ABSTRACT

BACKGROUND: Burning mouth syndrome remains a puzzling condition. One symptom commonly associated with the burning sensation is xerostomia. The current study measured basal and stimulated salivary flow in a group of burning mouth syndrome patients. METHODS: Three groups of patients were recruited: 44 burning mouth syndrome patients, 27 oral lichen planus patients and 40 healthy patients. We chose to measure basal salivary flow and stimulated salivary flow in the three groups of patients using the 'spitting' method. Thus, the patients were asked to spit every minute for 5 min. Afterwards, they were asked to repeat the procedure a second time, but a drop of citric acid was positioned on their tongue every minute to stimulate salivary secretion. After 14 days, the same procedure was repeated for 15 min. RESULTS: Although there was no significant difference between the burning mouth syndrome group and the other two groups regarding the stimulated volumes, an important difference was found in the basal volumes, with the burning mouth syndrome patients showing lower values. CONCLUSIONS: The outcomes of our research demonstrate the presence of very low basal salivary flow in burning mouth syndrome patients compared with the other two groups, but the stimulated salivary flow was equal, if not higher, in the burning mouth syndrome patients. This study contributes new topics for further investigation of a solution to the very mysterious pathology represented by burning mouth syndrome.


Subject(s)
Burning Mouth Syndrome/physiopathology , Saliva/metabolism , Secretory Rate/physiology , Adult , Aged , Aged, 80 and over , Citric Acid/pharmacology , Female , Follow-Up Studies , Humans , Lichen Planus, Oral/physiopathology , Male , Middle Aged , Saliva/drug effects , Secretory Rate/drug effects
11.
Article in English | MEDLINE | ID: mdl-23751268

ABSTRACT

The current clinical case highlights the diagnostic process in characterizing an unusual green macular lesion of the maxillary gingiva. A review of the history revealed that the patient had suffered trauma to the oral tissues during a soccer match 2 years prior. An incisional biopsy was performed and microscopic analysis demonstrated the presence of a granulomatous reaction to a needle-shaped, birefringent foreign material. Comparative analysis of a specimen collected from the soccer field confirmed that the foreign material was artificial grass. Foreign material was also found inside the gingival epithelial cells.


Subject(s)
Gingiva/pathology , Granuloma, Foreign-Body/diagnosis , Maxilla/pathology , Child , Humans , Male
12.
Prog Orthod ; 13(2): 109-16, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23021113

ABSTRACT

INTRODUCTION: Orthodontic tooth movement is characterized by tissue reactions, which consist in an inflammatory response in periodontal ligament, depending on the forces applied. Self-ligating brackets are able to minimize the sliding resistance and to reduce the forces necessary to move a tooth, with a better tissue response. OBJECTIVES: The purpose of this study was to evaluate the activity of the lactate dehydrogenase (LDH) in gingival crevicular fluid (GCF) during orthodontic tooth movement using self-ligating brackets. MATERIALS AND METHODS: Forty patients were selected and treated with two kinds of self-ligating brackets, Quick 2.0 and Smart Clip, and superelastic or thermoactive archwires. Patients' lower arches were bonded and GCF was collected at one side for each tooth at baseline, one hour after bonding and on the 7(th), 28(th) and 42(nd) day. Test teeth were 4.1, 4.3 and 4.5. Control teeth were 1.1, 1.3 and 1.5. Samples were analyzed with a specific assay for LDH activity. RESULTS: The statistical analysis showed no significant differences in the LDH activity between test and control teeth in the selected groups. CONCLUSIONS: There are no significant differences, in terms of tissue response, between superelastic and thermoactive archwires.


Subject(s)
Gingival Crevicular Fluid/enzymology , L-Lactate Dehydrogenase/analysis , Orthodontic Appliance Design , Orthodontic Brackets , Tooth Movement Techniques/instrumentation , Adolescent , Alloys/chemistry , Bicuspid/enzymology , Biomechanical Phenomena , Child , Cuspid/enzymology , Dental Alloys/chemistry , Dental Bonding , Dental Plaque Index , Dental Scaling , Elasticity , Female , Follow-Up Studies , Humans , Incisor/enzymology , Male , Nickel/chemistry , Orthodontic Wires , Periodontal Index , Surface Properties , Temperature , Titanium/chemistry
13.
J Electromyogr Kinesiol ; 21(6): 885-92, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21889363

ABSTRACT

BACKGROUND: Studies on the relationship between occlusal problems and the spine are of increasing interest. In this study, we monitored the sEMG activity of masticatory, neck, and trunk muscles during the treatment of scoliosis in young patients, and compared the data with a control of untreated group. SUBJECTS AND METHODS: Twelve white Caucasian patients (nine males and three females; mean age of 8.0±1.5 years) with scoliosis and Class I occlusion (without crowding) were included in this study (study group). Fifteen healthy subjects (nine males and six females; mean age of 9.5±0.8 years) were recruited as control group. The subjects were visited before they underwent the treatment of scoliosis, as well as after 3 (T1) and 6 months (T2) of their treatment for scoliosis. The patients were instructed to wear the device during sleep and during the day, according to the protocol given by their orthopedic. RESULTS: The treated group showed statistically significant changes in the sEMG activity of masticatory, neck, and trunk muscles, both at rest and during MVC of the mandible with respect to T0. The masseter and the anterior temporalis showed a significant improvement in the asymmetry index from T0 to T2. On the other hand, subjects in the control group did not register much change. CONCLUSION: Our findings suggest that the use of a functional device for the treatment of scoliosis induces a significant reduction in the asymmetry index of the trunk muscles, as well as a significant increase in the contractility of masticatory muscles.


Subject(s)
Abdominal Muscles/physiopathology , Braces , Electromyography , Masticatory Muscles/physiopathology , Neck Muscles/physiopathology , Scoliosis/physiopathology , Scoliosis/therapy , Child , Female , Humans , Longitudinal Studies , Male , Muscle Contraction , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...